Verified botanical batches produced under GMP-certified extraction protocols, inspected via gas chromatography-mass spectrometry (GC-MS) for pharmaceutical, dental topical, and personal oral care industries.
In modern dental phytotherapy and clinical endodontics, Clove Oil for Toothache remains an indispensable therapeutic active ingredient. Sourced predominantly from the flower buds, stems, and leaves of Syzygium aromaticum (syn. Eugenia caryophyllata), this botanical volatile extract owes its robust analgesic, anti-inflammatory, and antimicrobial properties to high concentrations of eugenol (4-allyl-2-methoxyphenol), along with secondary synergistic sesquiterpenes such as β-caryophyllene and eugenyl acetate.
The pharmacological mode of action against acute odontogenic pain (odontalgia), pulpal inflammation, and post-restoration dental sensitivity operates across three distinct biochemical pathways:
As the international oral hygiene and over-the-counter (OTC) pharmaceutical markets steer away from synthetic analgesics and halogenated preservatives, top-tier dental product manufacturers require certified, ultra-pure Clove Oil from established factories equipped with modern fractional distillation and rigorous quality control laboratories.
From rustic smallholder distillation units to automated continuous steam extraction and supercritical fluid fractionation facilities.
Global pharmaceutical purchasers no longer accept variable agricultural grades. Procurement criteria now demand batch uniformity compliant with the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Food Chemicals Codex (FCC), restricting eugenol content precisely between 85.0% and 95.0%.
Consumer aversion toward chlorhexidine, parabens, and synthetic local numbing agents (such as benzocaine) is pushing oral health brands to integrate purified Clove Oil and isolated eugenol complexes into dry socket dressings, restorative cements, and emergency toothache drop solutions.
While Indonesia and Madagascar remain primary cultivators of raw clove biomass, global brands increasingly route crude extract through modern Chinese processing hubs like Jiangxi Baicao Pharmaceutical for industrial molecular rectification, organochlorine stripping, and multi-tier lab verification.
Detailed critical quality attributes (CQAs) for international pharmaceutical registration, oral cosmetic safety assessments, and B2B batch qualification.
| Analytical Parameter | Pharmacopoeial Reference (USP / EP) | Factory Baseline Specification | Testing Methodology |
|---|---|---|---|
| Eugenol Assay Content | 85.0% - 95.0% (m/m) | ≥ 88.5% (High Assay Dental Grade) | Gas Chromatography with FID (GC-FID) |
| Appearance & Color | Clear, colorless to pale yellow liquid | Passes USP Color Index, darkened liquid rejected | Visual / Spectrophotometric absorbance |
| Refractive Index (20°C) | 1.528 – 1.537 | 1.530 – 1.535 | Automated Digital Refractometry |
| Relative Density (20°C) | 1.038 – 1.060 g/cm³ | 1.042 – 1.054 g/cm³ | Oscillating U-Tube Densitometry |
| Heavy Metals (Pb, Cd, As, Hg) | Total < 10.0 ppm; Individual limits strict | Lead < 1.0 ppm; Arsenic < 0.5 ppm | ICP-MS (Inductively Coupled Plasma) |
| Pesticide Residue Limits | Conforms to Ph. Eur. 2.8.13 | Zero detected multi-residue profile | GC-MS/MS & LC-MS/MS |
| Microbiological Bioburden | TAMC < 10² CFU/g; TYMC < 10¹ CFU/g | Absence of E. coli, P. aeruginosa, S. aureus | Membrane Filtration / Plate Count |
| Residual Solvents (ICH Q3C) | Class 1, 2, 3 below detection thresholds | Zero synthetic solvent residues (Steam Distilled) | Headspace Gas Chromatography (HS-GC) |
Every single production drum leaving Jiangxi Baicao Pharmaceutical is accompanied by a dual-verified Certificate of Analysis (COA), safety data sheets (MSDS/SDS) compliant with GHS/OSHA, and technical dossier data sheets suited for FDA NDC filings or EU Cosmetic Product Safety Reports (CPSR).
Inside our 28,600 m² GMP extraction facility located in the Jinggangshan Economic & Technological Development Area, Ji'an, Jiangxi Province.
Utilizing closed-loop, multi-plate stainless steel vacuum rectification towers that precisely isolate eugenol isomers from high-boiling resins and unpleasant sulfur traces. This process removes unwanted bitter aftertastes while stabilizing natural analgesic potency for oral mucosal applications.
Class 100,000 cleanroom workshops capable of automated filling into 5ml, 10ml, and 15ml amber glass dropper vials with child-resistant, tamper-evident caps and precision cotton applicator kits designed for immediate OTC toothache emergency relief lines.
Specialized batch treatment ensures minimal free moisture and zero acid contaminants, optimizing our Clove Oil as a reactive liquid phase for zinc oxide powders in temporary dental restorations, cavity linings, and endodontic root canal sealers.
Minimizing import friction, accelerating customs clearance, and securing pharmaceutical audit clearances worldwide.
Jiangxi Baicao Pharmaceutical supports international product registrations by supplying fully documented regulatory packages:
Because pure essential oils contain high flash-point volatiles, international freight demands specialized handling:
Bridging traditional phytotherapy with advanced polymer chemistry and targeted pharmaceutical delivery platforms.
Development of thermodynamic self-nanoemulsifying drug delivery systems (SNEDDS) incorporating Clove Oil. These formulations maximize transmucosal bioavailability through oral keratinized gingiva, initiating analgesic onset within 90 seconds while minimizing mucosal burning sensation.
Formulating poly(lactic-co-glycolic acid) (PLGA) bioresorbable microparticles loaded with pharmaceutical eugenol fractions. Engineered to provide 14-day sustained release in deep periodontal pockets to prevent post-extraction alveolar osteitis (dry socket syndrome).
Scientific mapping of eugenol’s specific activation-desensitization cycle on transient receptor potential ankyrin 1 (TRPA1) ion channels, opening pathways to hybrid non-opioid OTC analgesic formulations with extended pain-suppression durations.
Comprehensive technical and commercial clarifications for raw material buyers, formulators, and supply chain managers.
Clove Bud Oil exhibits a superior chemical profile characterized by high eugenol content (80–90%) coupled with 5–15% eugenyl acetate and lower quantities of harsh terpenes. Clove Leaf Oil, while higher in raw eugenol, has negligible eugenyl acetate and contains pungent sesquiterpene impurities that can trigger severe soft-tissue irritation on fragile gingival margins. Pharmaceutical and oral care formulations consistently designate Clove Bud Oil to achieve predictable analgesia without inducing oral epithelial ulceration.
We maintain strict quality control through automated fractional vacuum rectification, monitored via in-line digital refractometry and density sensors. Every raw lot is homogenized in 5-ton stainless steel blending vessels, followed by comprehensive GC-FID profiling against internal reference standards. If an agricultural lot shows lower eugenol concentration, our precision rectification towers concentrate the active fraction to maintain your specified monograph standard (e.g., 88.0% ± 1.5%) before bulk packaging.
For standard bulk drums (25kg carboys and 200kg steel drums), our standard lead time is 7 to 10 business days from purchase order confirmation to departure from Shanghai, Ningbo, or Shenzhen ports. The baseline MOQ for bulk pharmaceutical-grade Clove Oil is 25kg. For customized private label OEM toothache drop solutions (filled dropper bottles with retail secondary carton packaging), the standard MOQ begins at 5,000 units with an average lead time of 20 to 25 calendar days.
Yes. Our dedicated Regulatory Affairs team provides complete technical files containing detailed process flowcharts, validation reports, certificates of origin, allergen statements, residual solvent tests according to ICH Q3C, heavy metal impurity limits per USP <232>/<233>, and microbiological quality validation. We also facilitate supplier audits and complete customer vendor qualification questionnaires within 48 hours.
Complementary natural raw ingredients manufactured for therapeutic formulations, clinical personal care, and high-purity industrial synthesis.
Since 2010, Jiangxi Baicao Pharmaceutical Co., Ltd. has served as an essential primary extraction and refining partner for multi-national consumer health companies, flavor and fragrance institutions, and dental supply distributors.
Our dual-workshop facility operates twelve dedicated production lines, separating essential oil steam rectification from botanical powder spray drying. This eliminates any risk of allergen cross-contamination, ensuring every lot aligns with global cGMP requirements.
Connect directly with our export engineering department to request regulatory compliance packets, formal proforma pricing, and batch qualifying samples (100g to 500g analytical lots).